Supplied as a 50 mg lyophilized research compound with full COA traceability
Risks of Incorrect Reconstitution and When to Seek Advice Incorrect reconstitution of an unlicensed injectable peptide risks overdose, microbial contamination, chemical degradation, and injection site complications
Clear water turning milky or hazy points to microbial growth or a compatibility problem
Peptides are also being investigated as potential biomarkers for chronic diseases, which could revolutionize early diagnosis and treatment
2013 Mar Merav Jacobson Bensky, Irit Ayalon-Dangur, Roi Ayalon-Dangur, Eviatar Naamany, Anat Gafter-Gvili, Gideon Koren, Shachaf Shiber
This information is for educational purposes and is not medical advice